Michael Friedlander

Michael Friedlander

UNVERIFIED PROFILE

Are you Michael Friedlander?   Register this Author

Register author
Michael Friedlander

Michael Friedlander

Publications by authors named "Michael Friedlander"

Are you Michael Friedlander?   Register this Author

100Publications

3441Reads

7Profile Views

Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: A meta-analysis.

J Geriatr Oncol 2019 May 22. Epub 2019 May 22.

Cancer Care Centre, St George Hospital, Sydney, NSW, Australia; National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Sydney, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.05.013DOI Listing
May 2019

10-year performance of four models of breast cancer risk: a validation study.

Lancet Oncol 2019 Apr 21;20(4):504-517. Epub 2019 Feb 21.

Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, VIC, Australia; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30902-1DOI Listing
April 2019

The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis.

Breast Cancer Res Treat 2019 Feb 21;174(1):271-278. Epub 2018 Nov 21.

Cancer Care Centre, St George Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-5054-xDOI Listing
February 2019

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.

Obstet Gynecol 2019 Feb;133(2):245-254

Cleveland Clinic Foundation and Case Western Reserve University, Cleveland, Ohio; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York; The Ohio State University, Columbus, Ohio; the University of Minnesota, Minneapolis, Minnesota; Duke University Hospital; Durham, North Carolina; the University of California at Irvine, Orange, California; the University of Iowa Hospital, Iowa City, Iowa; Washington University in St. Louis School of Medicine, St. Louis, Missouri; ANZGOG, Australia-New Zealand Gynaecological Oncology Group, Sydney, Australia; the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Community Health Network and Indiana University School of Medicine, Indianapolis, Indiana; Walter Reed Army Medical Center; Bethesda, Maryland; Tacoma General Hospital, Tacoma, Washington; Moffitt Cancer Center, Tampa, Florida; the University of Colorado School of Medicine at Denver, Aurora, Colorado; Cancer Treatment Centers of America, Philadelphia Pennsylvania; NYU Clinical Cancer Center, New York, New York; Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland; US Oncology Research, Arizona Oncology, Tucson, Arizona; the University of Pennsylvania Medical Center, Philadelphia, Pennsylvania; and The Ohio State University Medical Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000003086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551603PMC
February 2019

Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancer.

Support Care Cancer 2018 Dec 12;26(12):4133-4142. Epub 2018 Jun 12.

Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Locked Bag 2000, Royal Brisbane Hospital, Brisbane, QLD, 4029, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4284-0DOI Listing
December 2018

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

N Engl J Med 2018 12 21;379(26):2495-2505. Epub 2018 Oct 21.

From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan-Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome (G.S.) - both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (A. Oaknin), and M.D. Anderson Cancer Centre Madrid, Madrid (A.G.-M.) - both in Spain; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia (M.F.); St. Petersburg City Oncology Dispensary, St. Petersburg, Russia (A. Lisyanskaya); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris (A.F., A. Leary), Institut Bergonié, Comprehensive Cancer Center, Bordeaux (A.F.), and Gustave-Roussy Cancer Campus, Villejuif (A. Leary) - all in France; the Netherlands Cancer Institute, Amsterdam (G.S.S.); Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (C.G.), the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London (S.B.), and AstraZeneca, Cambridge (R.B.) - all in the United Kingdom; Princess Margaret Cancer Centre, Toronto (A. Oza); Memorial Sloan Kettering Cancer Center, New York (C.A.); Froedtert and the Medical College of Wisconsin, Milwaukee (W.B.); Women and Infants Hospital, Providence, RI (C.M., P.D.); Dana-Farber Cancer Institute, Boston (J.L.); and AstraZeneca, Gaithersburg, MD (E.S.L.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1810858
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1810858DOI Listing
December 2018

Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparib.

Asia Pac J Clin Oncol 2018 Dec 26;14(6):459-464. Epub 2018 Nov 26.

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.13104DOI Listing
December 2018

The value of participating in clinical trials: the whole is greater than the sum of its parts.

Med J Aust 2018 Nov;209(10):424-425

Prince of Wales Hospital, Sydney, NSW.

View Article

Download full-text PDF

Source
November 2018

Cancer of the ovary, fallopian tube, and peritoneum.

Int J Gynaecol Obstet 2018 Oct;143 Suppl 2:59-78

Royal Hospital for Women, Randwick, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijgo.12614
Publisher Site
http://dx.doi.org/10.1002/ijgo.12614DOI Listing
October 2018

Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.

Gynecol Oncol 2018 09 25;150(3):527-533. Epub 2018 Jul 25.

Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, NSW, Australia; Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.07.013DOI Listing
September 2018

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis.

Ther Adv Med Oncol 2018 6;10:1758835918788500. Epub 2018 Aug 6.

NHMRC Clinical Trials Centre, Australia New Zealand Gynaecological Oncology Group, University of Sydney, Camperdown, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918788500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080081PMC
August 2018

Medicare-funded cancer genetic tests: a note of caution.

Med J Aust 2018 08;209(5):193-196

Prince of Wales Hospital and Community Health Services, Sydney, NSW.

View Article

Download full-text PDF

Source
August 2018

Resisting RECIST-Uniformity Versus Clinical Validity.

Int J Gynecol Cancer 2017 10;27(8):1619-1627

*Auckland City Hospital, Auckland, New Zealand; †Prince of Wales Hospital, Sydney, Australia; ‡Princess Margaret Cancer Centre, Toronto, Ontario Canada; §Department of Radiation Oncology, Loyol University, Chicago, IL; ‖Instituto Valenciano de Oncologia, Valencia, Spain; ¶Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Paris, France; and #Gynecologic Group Intergroup, Kingston, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001062DOI Listing
October 2017

Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required.

Am J Surg Pathol 2017 Oct;41(10):1433-1442

*Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research ¶Gynaecological Oncology, Royal North Shore Hospital, St Leonards †Department of Anatomical Pathology, Royal North Shore Hospital ∥University of Sydney #Department of Obstetrics and Gynecology, St George Hospital **University of NSW ‡‡Prince of Wales Clinical School, University of New South Wales, Sydney ††Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick ‡Department of Anatomical Pathology, SYDPATH, St Vincent's Hospital §The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598906PMC
October 2017

Erratum to: The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols.

Qual Life Res 2017 08;26(8):2249-2250

Central Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-017-1578-5DOI Listing
August 2017

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.

J Clin Oncol 2017 Jul 11;35(20):2329-2337. Epub 2017 Apr 11.

Goli Samimi, Charlisse F. Caga-anan, Michael Dean, Leah E. Mechanic, Lori M. Minasian, and Mark E. Sherman, National Cancer Institute; Lawrence C. Brody, National Human Genome Research Institute, Bethesda, MD; Marcus Q. Bernardini, Stephanie Lheureux, Patricia A. Shaw, Princess Margaret Cancer Centre, Toronto, Ontario; Janice S. Kwon, University of British Columbia; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Ian G. Campbell, Paul A. James, Masataka Takenaka, and David D. Bowtell, Peter MacCallum Cancer Centre; David D. Bowtell, University of Melbourne, Melbourne, Victoria; Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Michael Friedlander, The Prince of Wales Hospital; Susan J. Ramus, University of New South Wales; Susan J. Ramus and David D. Bowtell, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Fergus J. Couch, Mayo Clinic, Rochester, MN; Joanne A. de Hullu and Marline G. Harmsen, Radboud University Medical Center, Nijmegen, the Netherlands; Susan M. Domchek and Ronny Drapkin, University of Pennsylvania, Philadelphia; Phuong L. Mai, Magee-Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; Heather Spencer Feigelson, Kaiser Permanente Institute for Health Research, Denver, CO; Mia M. Gaudet, American Cancer Society, Atlanta, GA; Karen Hurley and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mark E. Robson, Weill Cornell Medical College, New York, NY; Felicitas Lacbawan, Quest Diagnostics Nichols Institute, San Juan Capistrano; Thomas P. Slavin, City of Hope, Duarte, CA; Evan R. Myers, Duke University Medical Center, Durham, NC; Lisa F. Rezende, FORCE: Facing Our Risk of Cancer Empowered, Tampa; Mark E. Sherman, Mayo Clinic, Jacksonville, FL; and Elizabeth M. Swisher, University of Washington Medical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501360PMC
July 2017

Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue.

J Pain Symptom Manage 2017 07 11;54(1):74-84. Epub 2017 May 11.

National Centre for Cancer Survivorship, The University of New South Wales, Sydney, Australia; Fatigue Clinic, Lifestyle Clinic, School of Medical Sciences, The University of New South Wales, Sydney, Australia; Viral Immunology Systems Program (VISP), The Kirby Institute, The University of New South Wales, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015DOI Listing
July 2017

Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer.

Int J Gynecol Cancer 2017 06;27(5):900-906

*Calvary Mater Newcastle, Newcastle; †National Health and Medical Research Council Clinical Trials Centre and ‡Westmead Institute for Medical Research, University of Sydney, Sydney; §Department of Gynaecological Oncology, Westmead Hospital, Westmead; and ∥School of Medicine, Western Sydney University; ¶Chris O'Brien Lifehouse; and #School of Medicine, University of Sydney, Sydney, New South Wales; **Royal Women's Hospital; ††University of Melbourne; ‡‡Division of Cancer Medicine, Peter MacCallum Cancer Centre; and §§Mercy Hospital for Women, Melbourne, Victoria; ∥∥Royal Brisbane and Women's Hospital and ¶¶School of Medicine, University of Queensland, Brisbane, Queensland; and ##Pathology North and ***Faculty of Health and Medicine, University of Newcastle, Newcastle; and †††Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000978DOI Listing
June 2017

Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer.

Best Pract Res Clin Obstet Gynaecol 2017 May 23;41:126-138. Epub 2016 Nov 23.

Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick, Australia; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpobgyn.2016.11.004DOI Listing
May 2017

A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.

Ther Adv Med Oncol 2017 Apr 31;9(4):269-285. Epub 2017 Jan 31.

Prince of Wales Clinical School, University of New South Wales Australia, Sydney, New South Wales, Australia Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834016687260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405994PMC
April 2017

Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study.

Acta Oncol 2016 16;55(2):226-33. Epub 2015 Jun 16.

b The QIMR Berghofer Medical Research Institute, Gynaecological Cancers Group , Brisbane , Queensland , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1054950DOI Listing
January 2017

Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer.

Asia Pac J Clin Oncol 2016 Dec;12(4):323-331

Royal Brisbane and Women's Hospital, Herston (Brisbane), Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12636DOI Listing
December 2016

70-Gene Signature in Early-Stage Breast Cancer.

N Engl J Med 2016 12;375(22):2199-2200

Prince of Wales Hospital, Sydney, NSW, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1612048DOI Listing
December 2016

The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols.

Qual Life Res 2016 10 13;25(10):2457-2465. Epub 2016 Jun 13.

Central Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-016-1339-xDOI Listing
October 2016

Neoadjuvant chemoradiation (modified Eilber protocol) versus adjuvant radiotherapy in the treatment of extremity soft tissue sarcoma.

J Med Imaging Radiat Oncol 2016 Aug 3;60(4):539-44. Epub 2016 Mar 3.

Department of Surgery, Prince of Wales Hospital, Randwick, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1754-9485.12442DOI Listing
August 2016

Role of GABAA-Mediated Inhibition and Functional Assortment of Synapses onto Individual Layer 4 Neurons in Regulating Plasticity Expression in Visual Cortex.

PLoS One 2016 3;11(2):e0147642. Epub 2016 Feb 3.

Virginia Tech Carillion Research Institute, 2 Riverside Circle, Roanoke, Virginia 24016, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147642PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739708PMC
July 2016

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.

Authors:
Chenjie Zeng Xingyi Guo Jirong Long Karoline B Kuchenbaecker Arnaud Droit Kyriaki Michailidou Maya Ghoussaini Siddhartha Kar Adam Freeman John L Hopper Roger L Milne Manjeet K Bolla Qin Wang Joe Dennis Simona Agata Shahana Ahmed Kristiina Aittomäki Irene L Andrulis Hoda Anton-Culver Natalia N Antonenkova Adalgeir Arason Volker Arndt Banu K Arun Brita Arver Francois Bacot Daniel Barrowdale Caroline Baynes Alicia Beeghly-Fadiel Javier Benitez Marina Bermisheva Carl Blomqvist William J Blot Natalia V Bogdanova Stig E Bojesen Bernardo Bonanni Anne-Lise Borresen-Dale Judith S Brand Hiltrud Brauch Paul Brennan Hermann Brenner Annegien Broeks Thomas Brüning Barbara Burwinkel Saundra S Buys Qiuyin Cai Trinidad Caldes Ian Campbell Jane Carpenter Jenny Chang-Claude Ji-Yeob Choi Kathleen B M Claes Christine Clarke Angela Cox Simon S Cross Kamila Czene Mary B Daly Miguel de la Hoya Kim De Leeneer Peter Devilee Orland Diez Susan M Domchek Michele Doody Cecilia M Dorfling Thilo Dörk Isabel Dos-Santos-Silva Martine Dumont Miriam Dwek Bernd Dworniczak Kathleen Egan Ursula Eilber Zakaria Einbeigi Bent Ejlertsen Steve Ellis Debra Frost Fiona Lalloo Peter A Fasching Jonine Figueroa Henrik Flyger Michael Friedlander Eitan Friedman Gaetana Gambino Yu-Tang Gao Judy Garber Montserrat García-Closas Andrea Gehrig Francesca Damiola Fabienne Lesueur Sylvie Mazoyer Dominique Stoppa-Lyonnet Graham G Giles Andrew K Godwin David E Goldgar Anna González-Neira Mark H Greene Pascal Guénel Lothar Haeberle Christopher A Haiman Emily Hallberg Ute Hamann Thomas V O Hansen Steven Hart Jaana M Hartikainen Mikael Hartman Norhashimah Hassan Sue Healey Frans B L Hogervorst Senno Verhoef Carolyn B Hendricks Peter Hillemanns Antoinette Hollestelle Peter J Hulick David J Hunter Evgeny N Imyanitov Claudine Isaacs Hidemi Ito Anna Jakubowska Ramunas Janavicius Katarzyna Jaworska-Bieniek Uffe Birk Jensen Esther M John Charles Joly Beauparlant Michael Jones Maria Kabisch Daehee Kang Beth Y Karlan Saila Kauppila Michael J Kerin Sofia Khan Elza Khusnutdinova Julia A Knight Irene Konstantopoulou Peter Kraft Ava Kwong Yael Laitman Diether Lambrechts Conxi Lazaro Loic Le Marchand Chuen Neng Lee Min Hyuk Lee Jenny Lester Jingmei Li Annelie Liljegren Annika Lindblom Artitaya Lophatananon Jan Lubinski Phuong L Mai Arto Mannermaa Siranoush Manoukian Sara Margolin Frederik Marme Keitaro Matsuo Lesley McGuffog Alfons Meindl Florence Menegaux Marco Montagna Kenneth Muir Anna Marie Mulligan Katherine L Nathanson Susan L Neuhausen Heli Nevanlinna Polly A Newcomb Silje Nord Robert L Nussbaum Kenneth Offit Edith Olah Olufunmilayo I Olopade Curtis Olswold Ana Osorio Laura Papi Tjoung-Won Park-Simon Ylva Paulsson-Karlsson Stephanie Peeters Bernard Peissel Paolo Peterlongo Julian Peto Georg Pfeiler Catherine M Phelan Nadege Presneau Paolo Radice Nazneen Rahman Susan J Ramus Muhammad Usman Rashid Gad Rennert Kerstin Rhiem Anja Rudolph Ritu Salani Suleeporn Sangrajrang Elinor J Sawyer Marjanka K Schmidt Rita K Schmutzler Minouk J Schoemaker Peter Schürmann Caroline Seynaeve Chen-Yang Shen Martha J Shrubsole Xiao-Ou Shu Alice Sigurdson Christian F Singer Susan Slager Penny Soucy Melissa Southey Doris Steinemann Anthony Swerdlow Csilla I Szabo Sandrine Tchatchou Manuel R Teixeira Soo H Teo Mary Beth Terry Daniel C Tessier Alex Teulé Mads Thomassen Laima Tihomirova Marc Tischkowitz Amanda E Toland Nadine Tung Clare Turnbull Ans M W van den Ouweland Elizabeth J van Rensburg David Ven den Berg Joseph Vijai Shan Wang-Gohrke Jeffrey N Weitzel Alice S Whittemore Robert Winqvist Tien Y Wong Anna H Wu Drakoulis Yannoukakos Jyh-Cherng Yu Paul D P Pharoah Per Hall Georgia Chenevix-Trench Alison M Dunning Jacques Simard Fergus J Couch Antonis C Antoniou Douglas F Easton Wei Zheng

Breast Cancer Res 2016 06 21;18(1):64. Epub 2016 Jun 21.

Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN, 37203-1738, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-016-0718-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962376PMC
June 2016

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.

Int J Gynecol Cancer 2016 May;26(4):648-54

Prince of Wales Hospital, Prince of Wales Clinical School UNSW, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841290PMC
May 2016

The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiative.

FASEB J 2016 Feb 2;30(2):507-14. Epub 2015 Oct 2.

*Health System, University of California, Davis, Sacramento, California, USA; The Graduate School, Wayne State University, Detroit, Michigan, USA; Graduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA; University of California, San Francisco, San Francisco, California, USA; Graduate School, University of Colorado, Anschutz Medical Campus, University of Colorado, Denver, Colorado, USA; Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health, Bethesda, Maryland, USA; Biomedical Research Education and Training and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; **Department of Microbiology and Immunology and Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA; and Virginia Tech Carilion School of Medicine and Research Institute, Roanoke, Virginia, USA

View Article

Download full-text PDF

Source
http://www.nihbest.org/wp-content/uploads/2015/10/FASEB2015.
Web Search
http://www.fasebj.org/cgi/doi/10.1096/fj.15-276139
Publisher Site
http://dx.doi.org/10.1096/fj.15-276139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188226PMC
February 2016

Dry eyes and AIs: If you don't ask you won't find out.

Breast 2015 Dec 28;24(6):694-8. Epub 2015 Sep 28.

Save Sight Institute, University of Sydney, Australia; Prince of Wales Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.08.008DOI Listing
December 2015

Cancer of the ovary, fallopian tube, and peritoneum.

Int J Gynaecol Obstet 2015 Oct;131 Suppl 2:S111-22

Royal Hospital for Women, Randwick, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijgo.2015.06.007DOI Listing
October 2015

Reply to M.G. McNamara et al and M.S. Copur et al.

J Clin Oncol 2015 Aug 29;33(23):2583-4. Epub 2015 Jun 29.

Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.8298DOI Listing
August 2015

An Exercise Intervention During Chemotherapy for Women With Recurrent Ovarian Cancer: A Feasibility Study.

Int J Gynecol Cancer 2015 Jul;25(6):985-92

*School of Medical Sciences, University of New South Wales Australia, Sydney, Australia; †Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia; ‡Gynaecological Oncology, Royal Hospital for Women, Sydney, Australia; §Royal Sydney Cancer Centre, Prince Alfred Hospital, Sydney, Australia; ∥Research Institute for Sport and Exercise, University of Canberra, Canberra, Australia; ¶School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000460DOI Listing
July 2015

Quantifying physical activity and the associated barriers for women with ovarian cancer.

Int J Gynecol Cancer 2015 May;25(4):577-83

*School of Medical Sciences, University of New South Wales Australia; †NSW Cancer Survivors Centre, Sydney; ‡The Canberra Hospital, Canberra; and §Royal Hospital for Women, Sydney, Australia.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000349DOI Listing
May 2015

Whole-genome characterization of chemoresistant ovarian cancer.

Nature 2015 May;521(7553):489-94

1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia [3] Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia [4] Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK [5] Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14410DOI Listing
May 2015

Stage IB2 adenosquamous cervical cancer diagnosed at 19-weeks' gestation.

Aust N Z J Obstet Gynaecol 2015 Feb 3;55(1):94-7. Epub 2014 Dec 3.

Royal Hospital for Women, Obstetrics and Gynaecology, Randwick, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajo.12281DOI Listing
February 2015

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:
Paolo Peterlongo Jenny Chang-Claude Kirsten B Moysich Anja Rudolph Rita K Schmutzler Jacques Simard Penny Soucy Rosalind A Eeles Douglas F Easton Ute Hamann Stefan Wilkening Bowang Chen Matti A Rookus Marjanka K Schmidt Frederieke H van der Baan Amanda B Spurdle Logan C Walker Felicity Lose Ana-Teresa Maia Marco Montagna Laura Matricardi Jan Lubinski Anna Jakubowska Encarna B Gómez Garcia Olufunmilayo I Olopade Robert L Nussbaum Katherine L Nathanson Susan M Domchek Timothy R Rebbeck Banu K Arun Beth Y Karlan Sandra Orsulic Jenny Lester Wendy K Chung Alex Miron Melissa C Southey David E Goldgar Saundra S Buys Ramunas Janavicius Cecilia M Dorfling Elizabeth J van Rensburg Yuan Chun Ding Susan L Neuhausen Thomas V O Hansen Anne-Marie Gerdes Bent Ejlertsen Lars Jønson Ana Osorio Cristina Martínez-Bouzas Javier Benitez Edye E Conway Kathleen R Blazer Jeffrey N Weitzel Siranoush Manoukian Bernard Peissel Daniela Zaffaroni Giulietta Scuvera Monica Barile Filomena Ficarazzi Frederique Mariette Stefano Fortuzzi Alessandra Viel Giuseppe Giannini Laura Papi Aline Martayan Maria Grazia Tibiletti Paolo Radice Athanassios Vratimos Florentia Fostira Judy E Garber Alan Donaldson Carole Brewer Claire Foo D Gareth R Evans Debra Frost Diana Eccles Angela Brady Jackie Cook Marc Tischkowitz Julian Adlard Julian Barwell Lisa Walker Louise Izatt Lucy E Side M John Kennedy Mark T Rogers Mary E Porteous Patrick J Morrison Radka Platte Rosemarie Davidson Shirley V Hodgson Steve Ellis Trevor Cole Andrew K Godwin Kathleen Claes Tom Van Maerken Alfons Meindl Andrea Gehrig Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Hansjoerg Plendl Karin Kast Kerstin Rhiem Nina Ditsch Norbert Arnold Raymonda Varon-Mateeva Barbara Wappenschmidt Shan Wang-Gohrke Brigitte Bressac-de Paillerets Bruno Buecher Capucine Delnatte Claude Houdayer Dominique Stoppa-Lyonnet Francesca Damiola Isabelle Coupier Laure Barjhoux Laurence Venat-Bouvet Lisa Golmard Nadia Boutry-Kryza Olga M Sinilnikova Olivier Caron Pascal Pujol Sylvie Mazoyer Muriel Belotti Marion Piedmonte Michael L Friedlander Gustavo C Rodriguez Larry J Copeland Miguel de la Hoya Pedro Perez Segura Heli Nevanlinna Kristiina Aittomäki Theo A M van Os Hanne E J Meijers-Heijboer Annemarie H van der Hout Maaike P G Vreeswijk Nicoline Hoogerbrugge Margreet G E M Ausems Helena C van Doorn J Margriet Collée Edith Olah Orland Diez Ignacio Blanco Conxi Lazaro Joan Brunet Lidia Feliubadalo Cezary Cybulski Jacek Gronwald Katarzyna Durda Katarzyna Jaworska-Bieniek Grzegorz Sukiennicki Adalgeir Arason Jocelyne Chiquette Manuel R Teixeira Curtis Olswold Fergus J Couch Noralane M Lindor Xianshu Wang Csilla I Szabo Kenneth Offit Marina Corines Lauren Jacobs Mark E Robson Liying Zhang Vijai Joseph Andreas Berger Christian F Singer Christine Rappaport Daphne Geschwantler Kaulich Georg Pfeiler Muy-Kheng M Tea Catherine M Phelan Mark H Greene Phuong L Mai Gad Rennert Anna Marie Mulligan Gord Glendon Sandrine Tchatchou Irene L Andrulis Amanda Ewart Toland Anders Bojesen Inge Sokilde Pedersen Mads Thomassen Uffe Birk Jensen Yael Laitman Johanna Rantala Anna von Wachenfeldt Hans Ehrencrona Marie Stenmark Askmalm Åke Borg Karoline B Kuchenbaecker Lesley McGuffog Daniel Barrowdale Sue Healey Andrew Lee Paul D P Pharoah Georgia Chenevix-Trench Antonis C Antoniou Eitan Friedman

Cancer Epidemiol Biomarkers Prev 2015 Jan 21;24(1):308-16. Epub 2014 Oct 21.

Sheba Medical Center, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294951PMC
January 2015

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

J Clin Oncol 2015 Jan 3;33(3):244-50. Epub 2014 Nov 3.

Bella Kaufman and Ronnie Shapira-Frommer, Sheba Medical Center, Tel Hashomer; Georgeta Fried, Institute of Oncology, Rambam Health Care Campus; Mariana Steiner, Linn Medical Centre, Haifa; Salomon M. Stemmer, Rabin Medical Center, Petah Tikva; Ayala Hubert, Hadassah-Hebrew University Hospital, Sharett Institute of Oncology; Ora Rosengarten, Shaare Zedek Medical Centre, Jerusalem, Israel; Rita K. Schmutzler, Center for Familial Breast and Ovarian Cancer and Center of Integrated Oncology, Cologne, Germany; M. William Audeh, Samuel Oschin Cancer Institute, Los Angeles, CA; Michael Friedlander, Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales; Gillian Mitchell, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia; Judith Balmaña, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Niklas Loman, Skånes Universitetssjuk Lund, Lund, Sweden; Karin Bowen and Anitra Fielding, AstraZeneca, Macclesfield, United Kingdom; and Susan M. Domchek, Basser Research Center and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.2728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057749PMC
January 2015

Outcomes and endpoints in cancer trials: bridging the divide.

Lancet Oncol 2015 Jan 29;16(1):e43-52. Epub 2014 Dec 29.

University of Toronto Princess Margaret Cancer Centre, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70380-8DOI Listing
January 2015

Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes.

BMC Cancer 2014 Dec 22;14:993. Epub 2014 Dec 22.

Brain and Mind Research Institute, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364586PMC
December 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S67-72

*EORTC, Department of Oncology, KU Leuven and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium; †GINECO, Department of Medical Oncology, Institut Bergonié, Bordeaux, France; ‡ANZGOG, Department of Clinical Oncology, Prince of Wales Hospital, Randwick, Australia; §NSGO, Department for Gynecologic Oncology and Institute for Medical Informatics, Oslo University Hospital, Oslo, Norway; ∥AGO, Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ¶KGOG, Women's Cancer Clinic, Division of Gynecologic Oncology, Institute of Women's Life Medical Science, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, South Korea; #GOG, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, United States of America, **GINECO, Centre Léon Bérard, Lyon, France; ††SGCTG, Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ‡‡ANZGOG, Department of Obstetrics and Gynaecology, University of Otago, Christchurch, New Zealand; §§DGOG, Department of Medical Oncology, Academic Medical Center, Amsterdam, the Netherlands; and ∥∥MRCP, FRCR, Department of Oncology, University College Hospital London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000205DOI Listing
November 2014

Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012.

Int J Gynecol Cancer 2014 Nov;24(9):1686-92

*Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, British Columbia, Canada; †Department of Medical Psychology and Psychotherapy, Medical University of Graz, Graz, Austria; ‡Department of Clinical Oncology, Leiden UniversityMedical Center, Leiden, the Netherlands; §EORTC, Brussels, Belgium; ∥Department of Gynecologic Oncology, Karolinska University Hospital, Stockholm, Sweden; ¶Department of Medical Oncology, The Prince of Wales Hospital, University of New South Wales Clinical School, Sydney, Australia; and #Departments of Medical Oncology and Clinical Research, Centre Francois Baclesse, CHU Côte de Nacre, University of Basse Normandie, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000245DOI Listing
November 2014

Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action!

Int J Gynecol Cancer 2014 Nov;24(9):1693-9

*Medical Oncology Department, Clinical Research Department, Centre Francois Baclesse, CHU Côte de Nacre, Inserm "cancer&preventions", University of Basse Normandie, Caen, France; †Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada; ‡Department of Clinical Oncology, University Medical Center, Leiden, the Netherlands; §Department of Gynaecologic Oncology, Karolinska University Hospital, Stockholm, Sweden; ∥EORTC, Brussells, Belgium; and ¶Department of Medical Oncology, The Prince of Wales Hospital, University of New South Wales Clinical School, Sydney, Australia.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000299DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S14-9

*UCL Cancer Institute and UCL Hospitals, London UK; †Hartford Hospital, Hartford, CT; ‡University of Louisville School of Medicine, Louisville, KY; §IRCCS San Raffaele Hospital, Milan, Italy; ∥The Prince of Wales Hospital Randwick, New South Wales, Australia; ¶Gynecologic Oncology Center, Kiel, Germany; #Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark; **Seoul National University College of Medicine, Seoul, Korea; ††Paris Descartes University, Cochin-Hôtel Dieu, Paris; ‡‡Princess Margaret Hospital, Toronto, Canada; and §§MD Anderson Cancer Centre, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000296DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S30-4

*Beatson Oncology Centre, Glasgow, UK; †Institut Gustave Roussy, Villejuif, France; ‡Karolinska Intitute, Stockholm, Sweden; §Samsung Medical Centre, Sung Kyun Kwan University Medical Centre, Seoul, South Korea; ¶University of Duisberg, Essen, Germany; ∥National Health and Medical Research Council, Clinical Trials Centre, New South Wales, Australia; #Princess Margaret Hospital, Toronto, Canada; **Flinders Centre for Innovation in Cancer, South Australia, Australia; ††Centre hospitalier de l'Universite de Montreal, Montreal, Canada; and ‡‡Centre Leon Berard, Lyon, France.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000293DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S35-41

*Beatson Oncology Centre, Glasgow, Scotland, United Kingdom (EORTC); †Centro Oncologico Estatal, ISSEMYM, Toluca de Lerdo, Mexico (GICOM); ‡Instituto Nacional de Cancerología, Tlalpan, Mexico (GICOM); §Mayo Clinic, Rochester, MN (GOG); ∥UKGM, Marburg, Germany (AGO); ¶NHMRC Clinical Trials Centre, New South Wales, Australia (ANZGOG); #Flinders Centre for Innovation in Cancer, South Australia (ANZGOG); **Seoul National University of Medicine, Seoul, Korea (KGOG); ††Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy (MaNGO); ‡‡Rigshospitalet, Copenhagen, Denmark (NSGO); and §§Centre Leon Berard, Lyon, France (GINECO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000265DOI Listing
November 2014

Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S48-54

*University of Texas MD Anderson Cancer Center, Houston, TX (Gynecologic Oncology Group [GOG]); †Prince of Wales Hospital, Sydney, Australia (Australia and New Zealand Gynecological Oncology Group [ANZGOG]); ‡The Ohio State University, Columbus, OH (GOG); §Kliniken Essen-Mitte, Essen, Germany (AGO); ∥University of Louisville, Louisville, KY (GOG); ¶Institut Curie, Hôpital Rene Huguenin, Saint Cloud, France (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [GINECO]); #Fondazione IRCCS National Cancer Institute of Milan, Italy (Multicentre Italian Trials in Ovarian Cancer); **Tampere University Hospital, Tampere, Finland (Nordic Society of Gynaecological Oncology); ††Seoul National University College of Medicine, Seoul, Korea (Korean Gynecologic Oncology Group); ‡‡The University of Chicago, Chicago, IL (GOG); and §§Charing Cross Hospital, London, UK (Medical Research Council/National Cancer Research Institute [MRC NCRI]).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000223DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S78-82

From the *Australia and New Zealand Gynecological Oncology Group (ANZGOG); †Sunnybrook Hospital, Toronto, Canada, (GOG); ‡Beatson West of Scotland Cancer Centre, Glasgow, Scotland, (SGCTG); §University Hospital of Schleswig-Holstein Campus Kiel, Germany, (AGO); ∥Norwegian Radium Hospital, Oslo, Norway, (NSGO); ¶School of Medicine, Dongsan Hospital, Keimyung University, Korea, (KGOG); #Centre Leon Berard, Lyon, France, (GINECO); **Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago, IL, (RTOG); ††University Medical Center, Utrecht Cancer Center, Utrecht, the Netherlands, (DGOG); and the ‡‡Department of Obstetrics Gynaecology and Neonatology, The University of Sydney, Sydney, New South Wales, Australia, (ANZGOG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000239DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S90-5

*Saitama Medical University International Medical Center, Saitama, Japan (GOTIC); †Hyogo Cancer Center, Akashi, Japan (GOTIC); ‡Harvard Medical School, Boston, MA (RTOG); §Southern General Hospital, Glasgow, Lanarkshire, UK; ¶Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK (SGCTG); ∥Hospices Civils de Lyon, Lyon, France (GINECO); #Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada (GOG); **Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy (MITO); ††Kliniken Essen Mitte, Essen, Germany (AGO); ‡‡Seoul National University College of Medicine, Seoul, Korea (KGOG); §§Institut Claudius Regaud, Toulouse, France (GINECO); ¶¶Instituto Nazionale Tumori, Napoli, Italy (MITO); and ∥∥Prince of Wales Hospital, Sydney, Australia (ANZGOG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000297DOI Listing
November 2014

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

J Clin Oncol 2014 Oct 15;32(30):3374-82. Epub 2014 Sep 15.

Andreas du Bois, Rainer Kimmig, Klaus H. Baumann, Christian Kurzeder, Ulrich Canzler, Philipp Harter, AGO Ovarian Cancer Study Group (AGO); Andreas du Bois, Christian Kurzeder, Philipp Harter, Kliniken Essen Mitte; Rainer Kimmig, West German Tumor Center, University of Duisburg-Essen, Essen; Joern Rau, Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg; Klaus H. Baumann, University of Marburg, Marburg; Ulrich Canzler, University Hospitals Carl Gustav Carus, Dresden, Germany; Anne Floquet, Isabelle Ray-Coquard, Marie-Ange Mouret-Reynier, Anne Lesoin, Eric Pujade-Lauraine, Groupe d'Investigateurs Nationaux pour l'Étude des Cancers Ovariens; Anne Floquet, Institut Bergonié, Bordeaux; Isabelle Ray-Coquard, Centre Léon Bérard, Lyon; Marie-Ange Mouret-Reynier, Centre Jean Perrin, Clermont-Ferrand; Anne Lesoin, Centre Oscar Lambret, Lille; Eric Pujade-Lauraine, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes, Paris, France; Jae-Weon Kim, Jae-Hoon Kim, Korean Gynecologic Oncology Group; Jae-Weon Kim, Seoul National University; Jae-Hoon Kim, Yonsei University; Byoung-Gie Kim, Samsung Medical Center, Seoul, Republic of Korea; Josep M. del Campo, Ivan Diaz-Padilla, Spanish Ovarian Cancer Research Group; Josep M. del Campo, Vall d'Hebron University Hospital, Barcelona; Ivan Diaz-Padilla, Centro Integral Oncologico Clara Campal, HM Hospitales, Madrid, Spain; Michael Friedlander, Paul Vasey, Australian and New Zealand Gynecological Oncology Group; Michael Friedlander, The Prince of Wales Clinical School University of New South Wales, Randwick, New South Wales; Paul Vasey, Wesley Medical Centre, Auchenflower, Queensland, Australia; Sandro Pignata, Giovanni Scambia, Multicenter Italian Trials in Ovarian Cancer; Sandro Pignata, Istituto Nazionale Tumori Fondazione G. Pascale, Naples; Nicoletta Colombo, Mario Negri Gynecologic Oncology Group and University of Milan-Bicocca and European Institute of Oncology, Milan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7348DOI Listing
October 2014

Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.

Med J Aust 2014 Sep;201(5):283-8

Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
September 2014

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

Int J Gynecol Cancer 2014 Jun;24(5):865-73

*School of Psychology and Psycho-Oncology Cooperative Research Group (PoCoG), University of Sydney, Sydney, NSW, Australia; and †ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; ‡Princess Margaret Hospital, Toronto, Ontario, Canada; and §School of Nursing, University of Pittsburgh, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/06000/Development_of_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000167DOI Listing
June 2014